Jiangsu Sihuan Bioengineering Co., Ltd (SHE:000518)

China flag China · Delayed Price · Currency is CNY
2.890
+0.010 (0.35%)
Apr 30, 2026, 11:54 AM CST
43.78%
Market Cap 2.97B
Revenue (ttm) 381.71M
Net Income (ttm) -32.49M
Shares Out 1.03B
EPS (ttm) -0.03
PE Ratio n/a
Forward PE n/a
Dividend n/a
Ex-Dividend Date n/a
Volume 4,112,000
Average Volume 13,757,973
Open 2.860
Previous Close 2.880
Day's Range 2.860 - 2.900
52-Week Range 1.720 - 3.180
Beta 0.26
RSI 45.44
Earnings Date Apr 18, 2026

About SHE:000518

Jiangsu Sihuan Bioengineering Co., Ltd., together with its subsidiaries, engages in the production and sales of biopharmaceutical products in China and internationally. The company offers Delusen and New Delusen, a human interleukin-2 for injection are immunomodulators used for the biotherapy of tumors and treatment of patients with weakened immune function; Xinlisheng, a human granulocyte colony-stimulating factor injection used to treat neutropenia caused by bone marrow transplantation, cancer chemotherapy, myelodysplastic syndrome, and aplas... [Read more]

Industry Biotechnology
Sector Healthcare
Founded 1992
Employees 277
Stock Exchange Shenzhen Stock Exchange
Ticker Symbol 000518
Full Company Profile

Financial Performance

In 2025, SHE:000518's revenue was 344.38 million, an increase of 69.22% compared to the previous year's 203.52 million. Losses were -37.09 million, -66.28% less than in 2024.

Financial Statements

News

There is no news available yet.